Recent Articles from Benzinga
Benzinga, founded in 2010 by Jason Raznick and headquartered in Detroit, Michigan, is a dynamic financial media and technology company dedicated to empowering individual investors with timely, actionable insights. Initially launched from Raznick’s basement with a modest $10,000 investment, the company has grown into a trusted resource, attracting approximately 25 million monthly readers through its innovative blend of real-time financial news, market analysis, and trading tools.
Website: https://www.benzinga.com
Target Corp (TGT) stock remained volatile despite upbeat Q3 earnings. Analysts have mixed views: BofA maintains Underperform with $80 PT, DA Davidson reaffirms Buy with $108 PT, JPMorgan retains Neutral with $100 PT, Telsey Advisory maintains Market Perform with $110 PT, and Needham stays Neutral.
Via Benzinga · November 20, 2025
Fartcoin's (CRYPTO: FART) breakout from a months-long downtrend may be the start of a 466% rally, if technical analysis confirms the breakout.
Via Benzinga · November 20, 2025
IREN shares are rising Thursday, capitalizing on a broader technology rally ignited by Nvidia's record-breaking third-quarter results.
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Palo Alto Networks, Inc. (NASDAQ:PANW) shares are trading lower Thursday on the heels of the company's fiscal first-quarter earnings results.
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Shoe Carnival stock falls as comps slip, despite margin gains, Shoe Station expansion, cost-savings plan, and raised earnings outlook.
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Cybersecurity ETFs rose even as Palo Alto fell post-earnings, signaling investors are backing the larger AI-driven security theme over near-term pressures.
Via Benzinga · November 20, 2025
FDA approves Regeneron's Eylea HD for retinal vein occlusion, adding extended dosing options and greater flexibility across multiple eye disease indications.
Via Benzinga · November 20, 2025
Three stocks in the digital-asset and blockchain space are making massive moves in Benzinga's Edge Stock Rankings.
Via Benzinga · November 20, 2025
Lowe's stock volatile despite upbeat earnings and analyst takeaways. Potential for home improvement rebound, HD favored over LOW.
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Shiba Inu (CRYPTO: SHIB) has posted a massive surge in burn activity alongside fresh ecosystem updates, hinting at rising network engagement despite
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
TEN stock surged after reporting strong Q3 2025 results, beating earnings and revenue estimates due to robust tanker markets.
Via Benzinga · November 20, 2025
BigBear.ai shares are climbing after the company unveiled a major AI partnership tied to Malaysia's emerging aerospace hub.
Via Benzinga · November 20, 2025
SoundHound AI shares are trading higher optimism in the technology sector following Nvidia's blockbuster third-quarter earnings report.
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Bitcoin's (CRYPTO: BTC) 28% drawdown below $90,000 has unleashed a wave of frustration and fresh bear-market calls by
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Shares of Verizon are trending Thursday. The telecommunications company is set to being laying off thousands of workers.
Via Benzinga · November 20, 2025
After Nvidia crushed earnings, ETFs across semiconductor, AI, and megacap tech, jumped as AI demand, global chip optimism fueled a broad rally.
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
AstraZeneca receives FDA approval for Koselugo to treat adults with NF1 and inoperable plexiform neurofibromas, backed by strong Phase 3 data.
Via Benzinga · November 20, 2025
Bath & Body Works (BBWI) disappointed with Q3 results, missed expectations, cut outlook due to weak consumer response, tough holiday season.
Via Benzinga · November 20, 2025
Oklo shares are trading higher Thursday morning, halting a recent 40% correction.
Via Benzinga · November 20, 2025
IBM and Cisco are building a distributed quantum computing network, enabling trillions of quantum gate computations.
Via Benzinga · November 20, 2025
The investment portfolios of Marjorie Taylor Greene and Warren Buffett's Berkshire Hathaway have some overlap with nine stocks in common.
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Nokia Oyj and NestAI have entered into a strategic alliance, supported by a combined 100 million euro ($115.3 million) investment.
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Bloom Energy Corp shares are trading higher Thursday morning, extending a rally driven by the company's pivot to powering AI data centers.
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Shares of Wix.Com were under pressure in early trading on Thursday, even after the company reported upbeat third-quarter earnings.
Via Benzinga · November 20, 2025
ExxonMobil acquires 40% stake in Enterprise's 550-mile Bahia NGL pipeline, expanding capacity to 1 million BPD and connecting Midland and Delaware basins to Mont Belvieu.
Via Benzinga · November 20, 2025
Nvidia's strong earnings and potential tariff policy relaxation by the Trump administration led to a rally in the semiconductor sector.
Via Benzinga · November 20, 2025
Marvell Technology, Inc plans to expand in India, hiring more talent and investing in R&D, to meet rising global demand for AI infrastructure.
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
CDC updates vaccine-autism language amid clashes between Robert F. Kennedy Jr. and Sen. Bill Cassidy, raising new questions over federal vaccine policy messaging.
Via Benzinga · November 20, 2025
Jacobs Solutions Inc. (NYSE:J) reported strong Q4 and full-year fiscal 2025 results, with revenue and adjusted earnings growth.
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
